Cargando…

Editorial: Establishment of marker models for molecular typing of renal cell carcinoma

Detalles Bibliográficos
Autores principales:	Jiang, Aimin, Zapała, Łukasz, Qu, Le, Wang, Linhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364634/ https://www.ncbi.nlm.nih.gov/pubmed/37492475 http://dx.doi.org/10.3389/fonc.2023.1236980

Ejemplares similares

Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2021)

Editorial: Molecular genetics and therapeutic advances in renal carcinoma
por: Nanus, David M., et al.
Publicado: (2023)

Editorial: Immunotherapy in renal cell carcinoma
por: Gruenwald, Viktor, et al.
Publicado: (2022)

Methods for Establishing a Renal Cell Carcinoma Tumor Spheroid Model With Immune Infiltration for Immunotherapeutic Studies
por: Lugand, Leonard, et al.
Publicado: (2022)

Editorial: Novel Molecular Targets and Treatments for Gastroesophageal Cancer
por: Lam, Alfred King-yin, et al.
Publicado: (2022)

PBRM1 Deficiency Sensitizes Renal Cancer Cells to DNMT Inhibitor 5-Fluoro-2’-Deoxycytidine
por: Gu, Di, et al.
Publicado: (2022)

Editorial: Influences in the progression of renal cell carcinoma
por: Bacchiani, Mara, et al.
Publicado: (2022)

Editorial: Case reports in renal cell carcinoma
por: Zhuang, Tony Z., et al.
Publicado: (2023)

Establishment and validation of a nomogram to select patients with metastatic sarcomatoid renal cell carcinoma suitable for cytoreductive radical nephrectomy
por: Zhou, Yulin, et al.
Publicado: (2023)

Editorial: Immune checkpoint inhibitors in renal cell carcinoma
por: Tykodi, Scott S., et al.
Publicado: (2023)

Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis
por: Jiang, Aimin, et al.
Publicado: (2022)

Establishment of an Ex Vivo Tissue Culture Model for Evaluation of Antitumor Efficacy in Clear Cell Renal Cell Carcinoma
por: Hong, Shanjuan, et al.
Publicado: (2022)

Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus
por: Gu, Yufeng, et al.
Publicado: (2023)

Editorial: Long-non coding RNAs in renal cell carcinoma
por: Wang, Zongping, et al.
Publicado: (2022)

Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
por: Petitprez, Florent, et al.
Publicado: (2021)

Establishment of a primary renal lymphoma model and its clinical relevance
por: Li, Xiaoxi, et al.
Publicado: (2023)

Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics
por: Shapiro, Daniel D., et al.
Publicado: (2022)

Editorial: Genetics and Molecular Mechanisms of Oral and Esophageal Squamous Cell Carcinoma
por: Qiao, Bin, et al.
Publicado: (2022)

Editorial: Molecular landscapes of human papillomavirus-related squamous cell carcinoma
por: Shen, Yujie, et al.
Publicado: (2023)

Editorial: The ever-changing scenario of first line treatment of metastatic renal cell carcinoma
por: Vitale, Maria Giuseppa, et al.
Publicado: (2023)

Single-Cell RNA Sequencing in Multiple Pathologic Types of Renal Cell Carcinoma Revealed Novel Potential Tumor-Specific Markers
por: Su, Cheng, et al.
Publicado: (2021)

Editorial: Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment
por: Zhang, Ruowen, et al.
Publicado: (2022)

The Four-Feature Prognostic Models for Cancer-Specific and Overall Survival after Surgery for Localized Clear Cell Renal Cancer: Is There a Place for Inflammatory Markers?
por: Zapała, Łukasz, et al.
Publicado: (2022)

A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2023)

Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis
por: Zhang, Peizhi, et al.
Publicado: (2023)

Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis
por: Ślusarczyk, Aleksander, et al.
Publicado: (2023)

Improving the prognostic accuracy in renal cell carcinoma with venous thrombus with novel predictive nomograms
por: Zapała, Łukasz, et al.
Publicado: (2022)

Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma
por: Tourigny, David S., et al.
Publicado: (2022)

An immune infiltration-related prognostic model of kidney renal clear cell carcinoma with two valuable markers: CAPN12 and MSC
por: Xia, Guang, et al.
Publicado: (2023)

Establishment and validation of a clinicopathological prognosis model of gastroenteropancreatic neuroendocrine carcinomas
por: Chen, Jing, et al.
Publicado: (2022)

Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2023)

A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

Identification and Verification of m(7)G Modification Patterns and Characterization of Tumor Microenvironment Infiltration via Multi-Omics Analysis in Clear Cell Renal Cell Carcinoma
por: Dong, Kai, et al.
Publicado: (2022)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

Advances in Renal Cell Carcinoma Drug Resistance Models
por: Xiang, Yien, et al.
Publicado: (2022)

Analysis of risk factors of hepatocellular carcinoma and establishment of a clinical prognosis model
por: Ge, Xin-Yu, et al.
Publicado: (2023)

Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice
por: Roberto, Michela, et al.
Publicado: (2021)

Renal-type Clear Cell Carcinoma Occurring in the Prostate With Zinner Syndrome
por: Sato, Yuichi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0b49etcr9n65gegqcmi1p0j6af